Back to Dashboard

TB-500 and Systemic Tissue Repair

Thymosin Beta-4 is the peptide behind systemic recovery — mobilising stem cells and rebuilding damaged tissue throughout the body. Here's what the science says.

What is TB-500?

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring protein that is found in virtually every human cell. Tβ4 plays a fundamental role in the polymerisation of actin — the structural protein that gives cells their shape and enables migration. TB-500 is a specific peptide fragment of Tβ4 (amino acids 17–23: LKKTETQ) that retains much of its bioactivity.

Mechanism of Action

TB-500 works through several interconnected pathways:

  • Actin Sequestration — Tβ4 binds to G-actin (globular actin), regulating the pool available for polymerisation. This controls cell shape, motility, and the structural response to injury.
  • Stem Cell Mobilisation — TB-500 signals bone marrow to release stem cells and progenitor cells into circulation, which then migrate to sites of damage.
  • Anti-inflammatory Action — Reduces levels of pro-inflammatory cytokines at injury sites, creating a more favourable environment for healing.
  • Cardiac Repair — Among the most studied applications: Tβ4 has been shown to recruit cardiac progenitor cells after myocardial infarction in animal models.

Systemic vs Local Effects

Unlike BPC-157, which works well with local injection, TB-500's primary strength is its systemic action. It circulates throughout the body and recruits repair mechanisms wherever damage exists. This makes it particularly valuable for:

  • Multiple simultaneous injuries
  • Chronic, diffuse conditions (e.g., fibromyalgia-like pain)
  • Post-surgery recovery when multiple areas need support

Research Highlights

Key findings from Tβ4/TB-500 research:

  • Accelerated corneal wound healing in animal models
  • Improved hair growth (follicle stem cell activation)
  • Cardiac muscle repair post-myocardial infarction in rodents
  • Enhanced tendon healing when combined with BPC-157
  • Neuroprotective effects in brain injury models

Typical Protocol

  • Loading phase: 5–10 mg/week for 4–6 weeks
  • Maintenance phase: 2–5 mg/week
  • Administration: SC or IM injection, remote site acceptable (systemic action)
  • Half-life: Approximately 48 hours

The BPC-157 + TB-500 Combination

These two peptides are commonly stacked because they complement each other's mechanisms perfectly:

  • BPC-157 — local angiogenesis, collagen remodelling, direct tendon/ligament repair
  • TB-500 — systemic stem cell recruitment, anti-inflammation, actin-driven cell migration

The result is faster, more complete tissue repair than either peptide achieves alone. This combination has become the go-to protocol for serious musculoskeletal injuries in the research community.